For the year ending 2025-12-31, PLYX has $5,170K in assets. $605K in debts. $5,143K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 5,143 | |||
| Other current assets | 27 | |||
| Total current assets | 5,170 | |||
| Total assets | 5,170 | |||
| Accounts payable | 470 | |||
| Due to related party | 91 | |||
| Accrued expenses related party | 23 | |||
| Accrued expenses and other current liabilities | 21 | |||
| Total current liabilities | 605 | |||
| Total liabilities | 605 | |||
| Common stock 0.0001 par value 560,000,000 shares authorized 47,343,297 and 41,151,571 shares issued and outstanding at december 31, 2025 and 2024, respectively | 5 | |||
| Additional paid-in capital | 104,195 | |||
| Accumulated deficit | -99,635 | |||
| Total stockholders equity | 4,565 | |||
| Total liabilities and stockholders equity | 5,170 | |||
Polaryx Therapeutics, Inc. (PLYX)
Polaryx Therapeutics, Inc. (PLYX)